Ibex Technologies (TSXV:IBT) FCF Margin % : 8.17% (As of Jan. 2024)

View and export this data going back to 1986. Start your Free Trial

What is Ibex Technologies FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Ibex Technologies's Free Cash Flow for the three months ended in Jan. 2024 was C$0.16 Mil. Ibex Technologies's Revenue for the three months ended in Jan. 2024 was C$1.92 Mil. Therefore, Ibex Technologies's FCF Margin % for the quarter that ended in Jan. 2024 was 8.17%.

As of today, Ibex Technologies's current FCF Yield % is 5.04%.

The historical rank and industry rank for Ibex Technologies's FCF Margin % or its related term are showing as below:

TSXV:IBT' s FCF Margin % Range Over the Past 10 Years
Min: -12.07 Med: 14.57 Max: 43.54
Current: 22.23

During the past 13 years, the highest FCF Margin % of Ibex Technologies was 43.54%. The lowest was -12.07%. And the median was 14.57%.

TSXV:IBT's FCF Margin % is ranked better than
92.34% of 1044 companies
in the Biotechnology industry
Industry Median: -139.2 vs TSXV:IBT: 22.23

Ibex Technologies FCF Margin % Historical Data

The historical data trend for Ibex Technologies's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ibex Technologies FCF Margin % Chart

Ibex Technologies Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

FCF Margin %

Get a 7-Day Free Trial

-12.07

24.30

17.68

43.54

16.55

Ibex Technologies Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
FCF Margin %	Get a 7-Day Free Trial															-34.55	4.55	64.37	18.90	8.17

Competitive Comparison of Ibex Technologies's FCF Margin %

For the Biotechnology subindustry, Ibex Technologies's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ibex Technologies's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ibex Technologies's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Ibex Technologies's FCF Margin % falls into.

Ibex Technologies FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Ibex Technologies's FCF Margin for the fiscal year that ended in Jul. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Jul. 2023 )	/	Revenue (A: Jul. 2023 )
	=	1.24	/	7.492
	=	16.55 %

Ibex Technologies's FCF Margin for the quarter that ended in Jan. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jan. 2024 )	/	Revenue (Q: Jan. 2024 )
	=	0.157	/	1.922
	=	8.17 %

Ibex Technologies FCF Margin % Related Terms

Thank you for viewing the detailed overview of Ibex Technologies's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ibex Technologies (TSXV:IBT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ibex Technologies Inc (TSXV:IBT) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

IBXNF:USA IBT:Germany

Address

5485 Pare Street, Suite 100, Montreal, QC, CAN, H4P 1P7

Website

https://www.ibex.ca

Ibex Technologies Inc is a company engaged in the production and sale of diagnostic products. It manufactures and markets enzymes for biomedical use, through its subsidiaries. It also manufactures and markets a series of arthritis assays that have applications in osteoarthritis research. It sells two product lines namely, Enzymes for in-vitro diagnostics and research, and Tests for osteoarthritis research. The group provides services like Filing and lyophilization of disposable diagnostic components, and Custom fermentation and purification of enzymes for diagnostic companies. Geographically, the firm sells its products in Canada, Germany, the U.S., the U.K., and other countries of which the majority of the revenue is generated from the U.S.

Ibex Technologies (TSXV:IBT) Headlines

No Headlines